Simon Keuerleber

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmaceutical Policy +16

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2–M Cell-Cycle Progression

Stefan Kastner, Tilman Voss, Simon Keuerleber et al. · Molecular Cancer Research · 2012 · 59 citations

Life Sciences, Molecular Biology, Oncology +12

Restricted Collision Coupling of the A2A Receptor Revisited

C. Charalambous, Ingrid Gsandtner, Simon Keuerleber et al. · Journal of Biological Chemistry · 2008 · 41 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Recruitment of a Cytoplasmic Chaperone Relay by the A2A Adenosine Receptor

Christian Bergmayr, Patrick Thurner, Simon Keuerleber et al. · Journal of Biological Chemistry · 2013 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13